Gilead
- All
- News
- Videos
-
EU Regulator Approves Twice-Yearly Injectable Drug For HIV Prevention
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
6.1 Lakh Remdesivir Vials, Oxygen Aid From Abroad Sent To States: Centre
Nineteen oxygen generation plants, 11,325 oxygen concentrators, 15,801 oxygen cylinders and about 6.1 lakh Remdesivir vials received as global aid have been dispatched to various states and Union territories from April 27 to May 17, the Centre said.
-
25,000 Doses Of Remdesivir From Gilead Sciences Reach India
The third consignment consisting of 25000 doses of Remdesivir from American biopharmaceutical company Gilead Sciences reached India on Saturday.
-
US Drugmaker To Donate 400,000 Covid Treatment Tablets To India
Eli Lilly and Co said on Tuesday it would supply 400,000 tablets of its COVID-19 treatment, to be used with Gilead's remdesivir, to India as the country fights a raging pandemic that has morgues and hospitals overflowing.
-
India To Import 4,50,000 Vials Of Anti-Viral Drug Remdesivir: Centre Amid Shortage
The government of India has started importing anti-viral drug Remdesivir from other countries and the first consignment of 75,000 vials will reach India today amid the ongoing Covid pandemic, Union Ministry of Chemicals and Fertilisers has said.
-
US Firm To Expand Remdesivir Availability In India; Donate 4.5 Lakh Vials
US Drug firm Gilead Sciences said it is taking several steps to expand the availability of antiviral drug Remdesivir in India and will also be donating a minimum of 4.5 lakh vials of 'Veklury' to the Indian government.
-
India Seeks Remdesivir, Oxygen From EU, Aid Expected Soon: EU Official
India has asked the European Union to send medical oxygen and Gilead's antiviral drug remdesivir to fight a surge in COVID-19 cases, an EU official said on Monday, adding that the aid could be made available soon.
-
WHO Removes Remdesivir From List Of Medicines Used As Benchmark
The World Health Organization said on Friday it has suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised COVID-19 patients.
-
WHO Says No Evidence Remdesivir Improves Survival, Gilead "Disappointed"
The World Health Organization recommended against using Gilead Sciences Inc.'s remdesivir to treat hospitalized Covid-19 patients less than a month after U.S. regulators granted the drug a speedy approval.
-
EU Regulator Approves Twice-Yearly Injectable Drug For HIV Prevention
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
6.1 Lakh Remdesivir Vials, Oxygen Aid From Abroad Sent To States: Centre
Nineteen oxygen generation plants, 11,325 oxygen concentrators, 15,801 oxygen cylinders and about 6.1 lakh Remdesivir vials received as global aid have been dispatched to various states and Union territories from April 27 to May 17, the Centre said.
-
25,000 Doses Of Remdesivir From Gilead Sciences Reach India
The third consignment consisting of 25000 doses of Remdesivir from American biopharmaceutical company Gilead Sciences reached India on Saturday.
-
US Drugmaker To Donate 400,000 Covid Treatment Tablets To India
Eli Lilly and Co said on Tuesday it would supply 400,000 tablets of its COVID-19 treatment, to be used with Gilead's remdesivir, to India as the country fights a raging pandemic that has morgues and hospitals overflowing.
-
India To Import 4,50,000 Vials Of Anti-Viral Drug Remdesivir: Centre Amid Shortage
The government of India has started importing anti-viral drug Remdesivir from other countries and the first consignment of 75,000 vials will reach India today amid the ongoing Covid pandemic, Union Ministry of Chemicals and Fertilisers has said.
-
US Firm To Expand Remdesivir Availability In India; Donate 4.5 Lakh Vials
US Drug firm Gilead Sciences said it is taking several steps to expand the availability of antiviral drug Remdesivir in India and will also be donating a minimum of 4.5 lakh vials of 'Veklury' to the Indian government.
-
India Seeks Remdesivir, Oxygen From EU, Aid Expected Soon: EU Official
India has asked the European Union to send medical oxygen and Gilead's antiviral drug remdesivir to fight a surge in COVID-19 cases, an EU official said on Monday, adding that the aid could be made available soon.
-
WHO Removes Remdesivir From List Of Medicines Used As Benchmark
The World Health Organization said on Friday it has suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised COVID-19 patients.
-
WHO Says No Evidence Remdesivir Improves Survival, Gilead "Disappointed"
The World Health Organization recommended against using Gilead Sciences Inc.'s remdesivir to treat hospitalized Covid-19 patients less than a month after U.S. regulators granted the drug a speedy approval.
